IPAB Repeal Bill Heads To House Floor
This article was originally published in The Gray Sheet
Executive Summary
A bill to eliminate the Independent Payment Advisory Board cleared two House panels last week. CBO says repeal could increase federal spending by $3.1 billion over 10 years, but adds that the actual impact is “extremely uncertain.”
You may also be interested in...
IPAB Raised At Debate; Romney Advisor Skeptical Board Will Ever Meet, Even If Obama Wins
Strict conflict-of-interest restrictions will make it very challenging to get people confirmed to serve on the Independent Payment Advisory Board, established under health reform, according to a top advisor to Mitt Romney. IPAB was a contentious issue in last week’s presidential debate.
IPAB Repeal Bill Clears House Subcommittee
House Energy and Commerce health panel votes to repeal Independent Payment Advisory Board. Ways and Means Committee plans a hearing March 6.
China’s Public Payer Wants To Define Innovative Drugs As Those With ‘Novel Benefits’
China’s public payer perceives innovative drugs in a different way from that of the country’s top drug regulator, a former senior healthcare security official with knowledge of the matter reveals. The posture has unnerved pharma companies, which have been hit by sharp price discounts.